Details for New Drug Application (NDA): 019151
✉ Email this page to a colleague
The generic ingredient in RYTHMOL is propafenone hydrochloride. There are eleven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.
Summary for 019151
Tradename: | RYTHMOL |
Applicant: | Glaxosmithkline Llc |
Ingredient: | propafenone hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019151
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 27, 1989 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 27, 1989 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 225MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 20, 1992 | TE: | RLD: | Yes |
Complete Access Available with Subscription